Skip to main content

Find Clinical Trials

Home
Conditions
Purpura

Clinical trial condition

Purpura

Explore clinical trials studying Purpura. Study availability and eligibility vary by location and protocol.

29 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Purpura trial results

Completed

LENS - Long-term Eltrombopag Observational Study

NCT00643929

Conditions: Blood Coagulation Disorders, Cataract, Eye Diseases, +10 more
Locations: GSK Investigational Site Tucson, Arizona, United States

GSK Investigational Site Washington D.C., District of Columbia, United States

GSK Investigational Site Detroit, Michigan, United States

GSK Investigational Site Durham, North Carolina, United States

View all 71 locations

View Trial Details

Completed

Promacta Pregnancy Registry

NCT01064336

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +10 more
Locations: Not specified

View Trial Details

Completed

rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP

NCT01525836

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Qilu Hospital, Shandong University Jinan, Shandong, China

View Trial Details

Completed

Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP)

NCT01506414

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Qilu Hospital, Shandong University Jinan, Shandong, China

View Trial Details

Completed

rhTPO Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of ITP

NCT01734044

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Qilu Hospital, Shandong University Jinan, Shandong, China

View Trial Details

Completed

Topical Vitamin A Versus Vehicle Cream in the Treatment of Aged Skin

NCT00272610

Conditions: Blood Coagulation Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

NCT01098487

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +13 more
Locations: GSK Investigational Site New York, United States

GSK Investigational Site Hradec Králové, Czechia

GSK Investigational Site Olomouc, Czechia

GSK Investigational Site Prague, Czechia

View all 34 locations

View Trial Details

Completed

Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)

NCT00424177

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: GSK Investigational Site Hanover, Lower Saxony, Germany

GSK Investigational Site Berlin, State of Berlin, Germany

GSK Investigational Site Moscow, Russia

View Trial Details

Completed

SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)

NCT00102739

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations: GSK Investigational Site Bad Nauheim, Hesse, Germany

GSK Investigational Site Athens, Greece

GSK Investigational Site Athens, Greece

GSK Investigational Site Thessaloniki, Greece

View all 30 locations

View Trial Details